St George’s, University of London is the UK’s only university dedicated to medical and health sciences education, training and research. In REF2014 St George’s was ranked fourth on the key measure of research impact. It was recently ranked 65th in the world for research influence by the Times Higher Education World University Rankings.

London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,900 students and more than 1,000 staff working in over 100 countries. The School was ranked top university in Europe for research impact in all fields (ahead of Oxford and Cambridge) in the 2015 CWTS Leiden Ranking. In 2014, it was ranked in the top 10 universities in the world for citation rate by the U-Multirank database and third in the world for social science and public health in the US News Best Global Universities Ranking. It was ranked second on the key measure of research impact in REF2014. The School was named the world’s leading research-focused graduate school in the Times Higher Education World Rankings in 2013.

Both institutions are specialist schools providing outstanding research training opportunities. Our training programmes provide a high quality research environment, an experienced and dedicated pool of supervisors and a suite of face-to-face and online transferable skills training modules to complement our specialist advanced short courses and postgraduate modules. Together, the programme and the environment provides world class integrated skills training and career development for biomedical and public health scientists to address MRC skills priorities in whole organism biology, quantitative skills and multi/interdisciplinary skills.

The infrastructure the partnership can offer includes:

  • An extensive, modularised Master’s degree and specialist short course programme which enables PhD students to undertake advanced training to meet their specific needs, including courses in advanced quantitative and qualitative methods; health policy; genetic epidemiology and bioinformatics; decision and economic analysis of health interventions; modelling the transmission dynamics of infectious diseases; genomic medicine.
  • The Wellcome Trust Bloomsbury Centre for Global Health Research, of which LSHTM and SGUL are core members, supports training and career development in global health research including infectious diseases, reproductive and maternal/child health, nutrition, mental health and health systems research. The Centre recruits the best young clinical and non-clinical scientists with an interest in global health research, to provide them with the support, training and academic environment they need to develop into independent researchers, and to facilitate their academic and clinical career progression. It works extensively with key partner institutions in Africa and Asia.
  • The Farr Institute of Health Informatics Research, is a collaboration between LSHTM, UCL, UCL Partners, Queen Mary University of London and PHE, bringing together a diverse group of people with interests in e-health records research to establish a centre of excellence in innovative health informatics research.
  • SGUL is a partner in the South London Genomic Medicine Centre, a preferred provider for the Health Education England MSc Genomic Medicine programme, and will provide access to training and infrastructure as part of Genomics England’s 100 000 Genome Project.
  • Computing infrastructure and statistical support which includes a High Performance Computer Cluster. LSHTM has one of the largest groups of statisticians and epidemiologists in the UK, has a strong track record of training in many areas of mathematics, statistics and advanced computational skills and is part of a research hub in statistical methods, providing students with access to specialised courses across the UK.
  • LSHTM and SGUL have formal training agreements with 18 international research centres, including our Associate Partner MRC units in The Gambia and Uganda, and access to large data sets and trials across low and middle income countries.


Comments are closed.